Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
about
CD10 expression in urothelial carcinoma of the bladderParaneoplastic consumptive coagulopathy related to intramyometrial low-grade endometrial stromal sarcoma coexistent with adenomyosis diagnosed 7 years after laparoscopic-assisted myomectomy.Recent advances in immunohistochemistry in gynaecological pathology.Case report of undifferentiated endometrial sarcoma in association with osteoclast-like giant cells.Cellular leiomyoma versus endometrial stromal tumor: A pathologists' dilemma.Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle.CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis.Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissueApplication of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.Endometrial stromal sarcoma: A review of the literatureMicroscopic endometrial perivascular epithelioid cell nodules: a case report with the earliest presentation of a uterine perivascular epithelioid cell tumor.The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors.The cytogenetics and molecular biology of endometrial stromal sarcoma.Extrauterine mixed endometrial stromal-smooth muscle tumor: Report of an unusual entity.Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China.Successful pregnancy following conservative management of low-grade endometrial stromal sarcoma: A case report.Endometrial stromal sarcoma presented as an incidental lung mass with multiple pulmonary nodules.Undifferentiated Endometrial Sarcoma of the Ovary: A Case Report with Review of Recent Literature and Discussion of Lacking Specificity of CD10 Immunoreactivity.Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.Gastrointestinal stromal tumours--an update for histopathologists.Recent developments in uterine mesenchymal neoplasms.Hepatic uterus-like mass misdiagnosed as hepatic abscess.High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.Endometrial stromal sarcoma--the new genetic paradigm.CD10 expression helps to differentiate basal cell carcinoma from trichoepitheliomaEstablishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle TumorsLow-Grade Endometrial Stromal Sarcoma with Intravenous and Intracardiac Extension: A Multidisciplinary Approach.Extensively Metastasizing Leiomyosarcoma: A Diagnostic Challenge.Low-grade endometrial stromal sarcoma in young age: a clinicopathological reportEndometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.Myxoid endometrial stromal sarcoma of the uterus.Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described.Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model.Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
P2860
Q24652806-6617BE54-BE30-46A6-88A4-CABA0AD820D9Q33388142-A7FFBEFE-251B-4CC8-9D5F-4B7333800EAAQ34593864-927FA4BC-13F2-4DFB-9A2F-89BF28771C72Q34955318-B9FB7587-CC1A-4611-ABBF-18D4440AA900Q35313841-5F86042D-D229-4F3E-AA04-1C7A877F23CDQ35563944-1E89089C-BBE5-4938-B318-24A2A515C702Q35586173-A9933BB6-7A13-41AA-84BC-4268849D6BC8Q35588355-CF6596DF-A06C-4901-AF4F-106056C45B2DQ35770511-53121343-ED60-4414-B471-BA86C7576E9BQ35770561-27249E03-78A1-4952-B630-A115962A21B4Q35789971-7405C243-CDA4-46FA-9520-ECD14E072C4AQ35847355-387C5660-BD67-439F-A2C9-BA0E45F2E5B2Q36064374-ED3125ED-A6F8-47A1-A2D7-81849E527346Q36367586-50A2BBF9-C607-41BF-B0E5-38A1FC51A511Q36671946-989A17D0-467E-4B2C-BFF3-9E82D6A6FA52Q36690945-A30694EB-9850-4054-AB4E-934F7D2BFFEAQ37000275-2A3FBA83-34BF-4CB1-A737-9ECDD2F132EDQ37481592-B5E8E508-110C-489E-9833-DE8B1A11A9A3Q37488781-00CBA555-3CA8-4EAA-A9F8-13943D808BB2Q37652478-9F36D64A-2108-41AB-9B12-3805283E163AQ37695627-E7DECBB6-1210-4C1E-9A26-944AD7E757D8Q37820128-EAA56C09-2548-41EB-8B19-D97FA75539B6Q37821354-807554F4-AEDD-4CFA-A882-79D1868DE5F0Q37888736-99CAC06C-7116-4944-8AC8-EDC48EA5B875Q38067441-EE6D6B92-D42E-47AC-B3E2-87FB0190CD29Q38211699-93BA79E9-E725-4E64-9792-C708B1E9135AQ38239833-E920682D-9C60-4763-A496-0AB53845BB68Q38263798-72F687B0-790F-4906-9C07-CBB3184C1E51Q38405626-77B8744C-994C-4D7F-8154-539A150DE7F3Q39993970-BD016C78-685D-45BF-980B-AF55D04B806CQ41078251-169774CA-C014-4D3C-8D79-4983076D488AQ41341058-9540456F-7BB6-4769-BF3B-CB99E70E9468Q42140342-D3787662-2743-4331-8B2D-6C79A57E3EA6Q42183421-66572663-7575-4E97-98F2-3FF678E16AD1Q44292906-629AB80D-9754-4B6C-A57C-7687888F51D7Q44594902-DD768D06-66BB-444B-A080-20EBB1F1E534Q44618246-A43157D7-D360-406A-B244-30F1DB1BFDB0Q45094167-AD38C234-A306-4CB7-BA94-1373B8913BD0Q45199929-03766780-FCA6-4707-A3DE-DFABF976DB04Q46413408-FB63400B-A0EB-41FF-AD74-7530ABD34489
P2860
Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@en
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@nl
type
label
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@en
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@nl
prefLabel
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@en
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@nl
P2093
P2860
P1433
P1476
Utility of CD10 in distinguish ...... emical comparison of 34 cases.
@en
P2093
P2860
P2888
P304
P356
10.1038/MODPATHOL.3880335
P577
2001-05-01T00:00:00Z